Express News | Moleculin Biotech Announces Enrollment In Investigator-Initiated Phase 2 Study Of WP1066 Combined With Radiation For Glioblastoma Treatment; Study Conducted At Northwestern University With NIH And BrainUp Funding

BenzingaSep 9 08:19 ET

Express News | Moleculin Announces First Patients Treated in Phase 2 Clinical Trial of Stat3 Inhibitor in Combination With Radiation for the Treatment of Glioblastoma

ReutersSep 9 08:15 ET

Moleculin Announces First Patients Treated in Phase 2 Clinical Trial of STAT3 Inhibitor in Combination With Radiation for the Treatment of Glioblastoma

PR NewswireSep 9 08:15 ET

Moleculin to Present at LIVE! With Webull Corporate Connect: Healthcare Investment Webinar

Moleculin BiotechAug 26 00:00 ET

Moleculin Announces Closing of up to $16.5 Million Public Offering

Moleculin BiotechAug 19 00:00 ET

Moleculin Biotech Secures Funding for Drug Development Programs

TipRanksAug 16 17:17 ET